These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9779602)

  • 21. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue.
    Qazzaz HM; Goudy SL; Valdes R
    J Biol Chem; 1996 Apr; 271(15):8731-7. PubMed ID: 8621507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
    Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
    Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma conjugated androgens in a dialysis-dependent male as immunoreactive digitalis-like factors.
    Longerich L; Johnson R; Brent D; Gault MH
    Clin Nephrol; 1990 Aug; 34(2):72-8. PubMed ID: 2171821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy.
    Hayashi T; Ijiri Y; Toko H; Shimomura H; Okabe M; Terasaki F; Kitaura Y; Kawamura K
    Eur Heart J; 2000 Feb; 21(4):296-305. PubMed ID: 10653677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
    Guédeney X; Chanez C; Grenier A; Scherrmann JM
    Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of digitalis compounds using a surface plasmon resonance-based biosensor.
    Laricchia-Robbio L; Balzan S; Ghione S; Montali U; Revoltella RP
    Biosens Bioelectron; 1998 Nov; 13(10):1055-60. PubMed ID: 9842700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for presence of a reduced form of digoxin-like immunoreactive factor (dihydro-DLIF) in mammalian tissues.
    Qazzaz HM; Jortani SA; Poole JM; Valdes R
    Clin Chem; 1996 Jul; 42(7):1092-9. PubMed ID: 8674194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB; Behrendt W; Stein T
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous digoxin-like immunoreactive factor is elevated in advanced chronic respiratory failure.
    Varsano S; Shilo L; Bruderman I; Dolev S; Shenkman L
    Chest; 1992 Jan; 101(1):146-9. PubMed ID: 1309496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of antibodies to ouabain.
    Terano Y; Tomii A; Masugi F
    Jpn J Med Sci Biol; 1991 Jun; 44(3):123-39. PubMed ID: 1664470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
    Qazzaz HM; Goudy S; Miller JJ; Valdes R
    Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain.
    Weinberg U; Dolev S; Werber MM; Shapiro MS; Shilo L; Shenkman L
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1024-9. PubMed ID: 1445339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
    Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
    Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.